Cargando…
Orlistat-Induced Gut Microbiota Modification in Obese Mice
INTRODUCTION: Accumulating evidence has indicated that alterations of gut microbiota have been involved in various metabolic diseases. Orlistat, a reversible inhibitor of pancreatic and gastric lipase, has beneficial effects on weight loss and metabolism. However, the effect of orlistat on the compo...
Autores principales: | Ke, Jing, An, Yaxin, Cao, Bin, Lang, Jianan, Wu, Nannan, Zhao, Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168719/ https://www.ncbi.nlm.nih.gov/pubmed/32328145 http://dx.doi.org/10.1155/2020/9818349 |
Ejemplares similares
-
Orlistat and ezetimibe could differently alleviate the high-fat diet-induced obesity phenotype by modulating the gut microbiota
por: Jin, Jin, et al.
Publicado: (2022) -
Obesity management: Update on orlistat
por: Drew, Belinda S, et al.
Publicado: (2007) -
Orlistat in the prevention of diabetes in the obese patient
por: Mancini, Marcio C, et al.
Publicado: (2008) -
Evaluation of efficacy and safety of orlistat in obese patients
por: Jain, Suyog S., et al.
Publicado: (2011) -
The Effect of Orlistat on Sterol Metabolism in Obese Patients
por: Kwon, Yu-Jin, et al.
Publicado: (2022)